American Select Portfolio (SLA) 10.66 $SLA Nuveen

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Select Portfolio (SLA) 10.66 $SLA

Nuveen Announces Additions to Closed-End Fund Product Line
Business Wire - Mon Sep 08, 8:25AM CDT
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced the addition of several closed-end funds to the Nuveen platform. Nuveen Fund Advisors, LLC now serves as advisor the American Income Fund, Inc. (MRF) which has been renamed the Nuveen Multi-Market Income Fund, Inc. and will trade under the symbol JMM. These changes were previously approved by shareholders at a meeting on July 28, 2014. The fund's investment strategy and portfolio managers remain unchanged.
MRF: 7.60 (-0.02), CSP: 7.40 (+0.03), DRA: 17.94 (+0.15), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), SLA: 10.66 (+0.10)

U.S. Bancorp Asset Management, Inc. Announces Distributions for Closed-End Funds
Business Wire - Tue Aug 26, 3:45PM CDT
U.S. Bancorp Asset Management, Inc. (NYSE:USB) today announced distributions for two closed-end funds which are expected to reorganize effective September 8, 2014.
CSP: 7.40 (+0.03), USB: 44.86 (+0.42), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), SLA: 10.66 (+0.10)

U.S. Bancorp Asset Management, Inc. Announces Financial Positions for Closed-End Funds
Business Wire - Fri Aug 22, 11:30AM CDT
U.S. Bancorp Asset Management, Inc. (NYSE:USB) today announced the financial positions for the following closed-end funds for the month ended July 31, 2014.
MRF: 7.60 (-0.02), CSP: 7.40 (+0.03), USB: 44.86 (+0.42), MXN: 14.54 (+0.10), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), MXA: 15.83 (+0.38), SLA: 10.66 (+0.10), XAA: 14.44 (-0.16)

American Strategic Income Portfolio Inc., American Strategic Income Portfolio Inc.-II, American Strategic Income Portfolio Inc.-III and American Select Portfolio Inc. Announce Results of Fund Shareholder Meetings
Business Wire - Fri Aug 15, 3:15PM CDT
American Strategic Income Portfolio Inc. (NYSE:ASP), American Strategic Income Portfolio Inc.-II (NYSE:BSP), American Strategic Income Portfolio Inc.-III (NYSE:CSP) and American Select Portfolio Inc. (NYSE:SLA) (each a "Fund" and, collectively, the "Funds" announced that, at the Special Meeting of Shareholders held today, shareholders of each Fund approved proposals to merge the Funds into a newly organized closed-end fund, Diversified Real Asset Income Fund (the "Combined Fund", which will be managed by Nuveen Fund Advisors, LLC and sub-advised by Nuveen Asset Management, LLC, both current sub-advisors of the Funds. These proposals approved by the Funds' shareholders are expected to become effective on September 8, 2014 (the "Nuveen Transition Date".
CSP: 7.40 (+0.03), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), SLA: 10.66 (+0.10)

Friday's Ex-Dividends To Watch: SLA, STON, MEMP
at The Street - Thu Jul 31, 9:05AM CDT
SLA STON MEMP are going ex-dividend Friday, Friday, Aug. 1, 2014, 4:00 AM ET
MEMP: 16.89 (+0.22), STON: 28.34 (-0.17), SLA: 10.66 (+0.10)

U.S. Bancorp Asset Management, Inc. Announces August Distributions for Closed-End Funds
Business Wire - Fri Jul 18, 11:30AM CDT
The closed-end funds listed below, which are advised by U.S. Bancorp Asset Management, Inc. (NYSE:USB), today declared their August distributions. The distributions will be allocated on a per-share basis on the common stock. The distributions have an ex-dividend date of August 1, 2014 and will be paid on August 20, 2014 to shareholders of record on August 5, 2014.
MRF: 7.60 (-0.02), CSP: 7.40 (+0.03), USB: 44.86 (+0.42), MXN: 14.54 (+0.10), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), MXA: 15.83 (+0.38), SLA: 10.66 (+0.10), XAA: 14.44 (-0.16)

3 Stocks With Upcoming Ex-Dividend Dates: SLA, KYE, DFT
at The Street - Mon Jun 30, 9:11AM CDT
SLA KYE DFT are going ex-dividend tomorrow, Tuesday, July 1, 2014, 4:00 AM ET
DFT: 34.72 (+1.31), KYE: 24.25 (+0.66), SLA: 10.66 (+0.10)

US Bancorp Asset Management declares July distributions for eight closed-end funds
M2 - Mon Jun 23, 6:29AM CDT
Investment advisor to the First American Closed-End Funds, US Bancorp Asset Management Inc (NYSE:USB), announced on Friday that the July distributions of closed-end funds listed below will be allocated on a per-share basis on the common stock.
MRF: 7.60 (-0.02), CSP: 7.40 (+0.03), USB: 44.86 (+0.42), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), XAA: 14.44 (-0.16), SLA: 10.66 (+0.10)

U.S. Bancorp Asset Management, Inc. Announces July Distributions for Closed-End Funds
Business Wire - Fri Jun 20, 11:20AM CDT
The closed-end funds listed below, which are advised by U.S. Bancorp Asset Management, Inc. (NYSE:USB), today declared their July distributions. The distributions will be allocated on a per-share basis on the common stock. The distributions have an ex-dividend date of July 1, 2014 and will be paid on July 16, 2014 to shareholders of record on July 3, 2014.
MRF: 7.60 (-0.02), CSP: 7.40 (+0.03), USB: 44.86 (+0.42), MXN: 14.54 (+0.10), ASP: 10.34 (+0.06), BSP: 8.91 (+0.06), MXA: 15.83 (+0.38), SLA: 10.66 (+0.10), XAA: 14.44 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 33

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 37

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 29

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 40

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 291

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
Exploring the Growing Trends in the US Coffee Market to 2034

Updated Category News Views 394

Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...

Continue Reading
Insights into Great Lakes Dredge & Dock's Upcoming Earnings

Updated Category News Views 125

Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...

Continue Reading
Calmére Estate Winery Sold, Signaling Growth in Napa Valley

Updated Category News Views 306

Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...

Continue Reading
Mr. Splash Car Wash Partners with NBA Stars for Growth

Updated Category News Views 204

Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...

Continue Reading